Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1.7M
-
Shares change
-
+36.5K
-
Total reported value, excl. options
-
$19.3M
-
Value change
-
+$436K
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$11.22
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q1 2022
16 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q1 2022.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.7M shares
.
Largest 10 shareholders include Roumell Asset Management, LLC (598K shares), INVESTMENT MANAGEMENT OF VIRGINIA LLC (444K shares), VILLERE ST DENIS J & CO LLC (266K shares), ARK Investment Management LLC (229K shares), BROWN ADVISORY INC (77.3K shares), BENJAMIN F. EDWARDS & COMPANY, INC. (75.3K shares), FNY Investment Advisers, LLC (5K shares), PNC Financial Services Group, Inc. (3.6K shares), UBS Group AG (3.43K shares), and SIMPLEX TRADING, LLC (825 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.